Literature DB >> 6262765

Structure of the turkey erythrocyte adenylate cyclase system.

T B Nielsen, P M Lad, M S Preston, E Kempner, W Schlegel, M Rodbell.   

Abstract

Target analysis of the turkey erythrocyte adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] system showed that the molecular weight of the ground state enzyme increases from 92,000 with MnATP as substrate and no stimulatory ligands to 226,000 when activated by fluoride ion or by 5'-guanyl imidodiphosphate (p[NH]ppG) subsequent to clearance of previously bound GDP. The identical increment in size (130,000) suggests that the same regulatory unit is involved in the activation by both effectors. When assayed with isoproterenol and p[NH]ppG, the enzyme system displayed a further increment in size of 90,000 daltons. Based on binding of the antagonist 125I-labeled hydroxybenzylpindolol, the beta-adrenergic receptor is about 90,000 daltons or the same as that seen for activation of the enzyme by isoproterenol through the beta-adrenergic-receptor. Because single targets were seen for the ground state enzyme system under all conditions, it would appear that the various regulatory and catalytic components are structurally linked prior to activation by hormone, guanine nucleotides, and fluoride ion. Furthermore, based on reported subunit sizes of the nucleotide regulatory and receptor components are composed of multiple subunits, either homologous or heterologous in structure.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262765      PMCID: PMC319874          DOI: 10.1073/pnas.78.2.722

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Evidence for distinct guanine nucleotide sites in the regulation of the glucagon receptor and of adenylate cyclase activity.

Authors:  P M Lad; A F Welton; M Rodbell
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

2.  Hydrodynamic properties of the beta-adrenergic receptor and adenylate cyclase from wild type and varient S49 lymphoma cells.

Authors:  T Haga; K Haga; A G Gilman
Journal:  J Biol Chem       Date:  1977-08-25       Impact factor: 5.157

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 4.  beta-Adrenergic receptor: ligand binding properties and the interaction with adenylyl cyclase.

Authors:  M E Maguire; E M Ross; A G Gilman
Journal:  Adv Cyclic Nucleotide Res       Date:  1977

5.  GTP-binding proteins in membranes and the control of adenylate cyclase activity.

Authors:  T Pfeuffer
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

6.  Evidence for interdependent action of glucagon and nucleotides on the hepatic adenylate cyclase system.

Authors:  M Rodbell; M C Lin; Y Salomon
Journal:  J Biol Chem       Date:  1974-01-10       Impact factor: 5.157

7.  Binding of (125I)iodohydroxybenzylpindolol to putative beta-adrenergic receptors of rat glioma cells and other cell clones.

Authors:  M E Maguire; R A Wiklund; H J Anderson; A G Gilman
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

8.  Beta-Adrenergic receptor interactions. Characterization of iodohydroxybenzylpindolol as a specific ligand.

Authors:  E M Brown; G D Aurbach
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

9.  Activation of pigeon erythrocyte membrane adenylate cyclase by guanylnucleotide analogues and separation of a nucleotide binding protein.

Authors:  T Pfeuffer; E J Helmreich
Journal:  J Biol Chem       Date:  1975-02-10       Impact factor: 5.157

10.  Solubilization and separation of the glucagon receptor and adenylate cyclase in guanine nucleotide-sensitive states.

Authors:  A F Welton; P M Lad; A C Newby; H Yamamura; S Nicosia; M Rodbell
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

View more
  6 in total

1.  Putative calcium channel molecular weight determination by target size analysis.

Authors:  D R Ferry; A Goll; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-08       Impact factor: 3.000

2.  Size determination of an equilibrium enzymic system by radiation inactivation: theoretical considerations.

Authors:  P Simon; S Swillens; J E Dumont
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

3.  Size of bacterial ice-nucleation sites measured in situ by radiation inactivation analysis.

Authors:  A G Govindarajan; S E Lindow
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  Clinical importance of DNA content in rectal cancer measured by flow cytometry.

Authors:  J R Jass; K Mukawa; H S Goh; S B Love; D Capellaro
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

5.  Increased dose-response relationship of liver plasma membrane adenylate cyclase to glucagon stimulation in diabetic rats. A possible role of the guanyl nucleotide-binding regulatory protein.

Authors:  H Allgayer; W Bachmann; K D Hepp
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

6.  Radiation inactivation of alpha 1-adrenoceptors.

Authors:  F Lübbecke; D R Ferry; H Glossmann; E L Sattler; G Doell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.